CJC-1295 DAC
CJC-1295 DAC is a highly purified synthetic Growth Hormone-Releasing Hormone (GHRH) analog engineered with Drug Affinity Complex (DAC) technology to provide prolonged biological activity under experimental conditions. The addition of the DAC moiety significantly extends the peptide’s circulating half-life, making CJC-1295 DAC one of the most extensively studied long-acting GHRH analogs in endocrine and peptide research. Its unique pharmacokinetic profile allows researchers to investigate sustained receptor activation, neuroendocrine regulation, and hormone-mediated signaling with greater precision.
Researchers employ CJC-1295 DAC to examine the physiological mechanisms that regulate Growth Hormone (GH) secretion and Insulin-Like Growth Factor-1 (IGF-1) production through activation of the Growth Hormone-Releasing Hormone Receptor (GHRHR). Experimental investigations continue to explore its effects on endocrine signaling, intracellular communication, metabolic regulation, protein synthesis, cellular growth pathways, and peptide-receptor pharmacology. These studies have established CJC-1295 DAC as an important research tool for understanding the complex interactions that govern hormone regulation and peptide signaling.
The prolonged activity of CJC-1295 DAC provides researchers with an effective model for studying sustained endocrine responses, receptor dynamics, and long-term peptide exposure in controlled laboratory environments. Its defined molecular structure and extensive scientific literature have made it a preferred compound in academic institutions, biotechnology organizations, and pharmaceutical research laboratories conducting advanced investigations into endocrinology, molecular biology, and peptide pharmacology.
Manufacturers produce CJC-1295 DAC as a high-purity, research-grade lyophilized peptide using stringent manufacturing protocols and comprehensive analytical quality control. Every production batch undergoes rigorous testing to verify identity, purity, potency, and batch-to-batch consistency, ensuring dependable performance and reproducible experimental results.
Product Information
- Product Name: CJC-1295 DAC
- Strength: 5mg per vial
- Full Name: Growth Hormone-Releasing Hormone Analog with Drug Affinity Complex
- Peptide Class: Long-acting synthetic GHRH analog
- Technology: Drug Affinity Complex (DAC)
- Appearance: White to off-white lyophilized powder
- Grade: Research grade
- Purity: High purity (Certificate of Analysis available for applicable batches)
- Intended Use: Laboratory research only
Research Applications
Researchers commonly investigate CJC-1295 DAC (5mg) in studies involving:
- Growth Hormone-Releasing Hormone (GHRH) receptor signaling
- Growth Hormone (GH) regulation
- Insulin-Like Growth Factor-1 (IGF-1) pathways
- Endocrine and neuroendocrine biology
- Peptide-receptor pharmacology
- Cellular signaling and molecular biology
- Metabolic and protein synthesis research
- Biotechnology and pharmaceutical research
Quality Assurance
Every batch of CJC-1295 DAC undergoes extensive analytical testing to confirm identity, purity, potency, and batch-to-batch consistency before release. Comprehensive quality assurance procedures support reliable laboratory performance and reproducible scientific investigations across research institutions, biotechnology companies, and pharmaceutical laboratories.
Storage
Store the lyophilized peptide in a cool, dry laboratory environment protected from moisture, excessive heat, and direct light. After reconstitution, follow validated laboratory storage protocols to preserve peptide stability and maintain sample integrity throughout the research process.
Disclaimer
CJC-1295 DAC (5mg) is supplied exclusively for scientific and laboratory research purposes. This product is not intended for human consumption, clinical use, veterinary applications, therapeutic treatment, or diagnostic procedures. Qualified laboratory professionals should handle this peptide in accordance with established laboratory practices, institutional guidelines, and all applicable regulations.






Reviews
There are no reviews yet.